U.S. market Closed. Opens in 13 hours 5 minutes

XTLB | XTL Biopharmaceuticals Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
RevenueN/AN/AN/AN/AN/A52.00K29.00K23.00K-6.00K41.00K2.37M938.00KN/AN/AN/A5.94M907.00K454.00K3.20M3.45MN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/A1.00K3.00K7.00K17.00741.00K380.00KN/AN/AN/A-5.63M110.00K54.00K2.80M3.30MN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A52.00K28.00K20.00K-13.00K40.98K1.63M558.00KN/AN/AN/A11.57M797.00K400.00K400.00K153.00KN/AN/AN/A
Operating Expenses765.00K880.00K1.03M948.00K842.00K793.00K1.25M1.71M2.00M2.02M3.85M3.70M1.16M1.26M2.29M15.53M26.53M16.45M13.00M16.93M-14.56M17.71M15.12M
Selling, General & Admin734.00K850.00K1.00M910.00K807.00K755.00K1.19M1.26M1.41M1.72M3.67M3.55M1.00M1.22M2.43M5.14M5.58M5.58M5.46M4.13M3.10M3.64M3.00M
Research & Development31.00K30.00K30.00K38.00K35.00K38.00K43.00K443.00K578.00K278.00K113.00K99.00K158.00K64.00KN/A10.39M20.95M10.87M7.54M12.79M11.10M13.16M11.05M
Other Operating ExpensesN/AN/AN/AN/AN/AN/A9.00K8.00K7.00K25.00K71.00K-802.00K12.00K-30.00K-139.00KN/AN/AN/AN/AN/A-28.77M916.00K1.07M
Operating Income-765.00K-880.00K-1.03M-948.00K-842.00K-793.00K-1.25M-2.56M-3.61M-2.02M-2.89M-2.36M-1.16M-1.26M2.57M-9.59M-25.73M-16.05M-14.38M-16.78M14.56M-17.71M-15.12M
Other Expenses / Income-1.02M-468.00K1.47M-2.01M79.00K3.78M465.00K16.00K-1.62M-97.00K-2.52M614.00K17.00K-1.00K-4.00K314.00K590.00K1.14M-1.57M352.00K-28.77M597.00KN/A
Before Tax Income-1.78M-1.35M435.00K-782.00K-1.35M2.99M-781.00K-2.54M-3.62M-2.12M-3.71M-1.74M-1.21M-1.26M2.56M-9.28M-25.14M-14.90M-13.94M-16.42M-14.21M-17.11MN/A
Income Tax ExpensesN/A468.00K-1.47M-166.00K-69.00K-7.64M-457.00K832.00K2.31M505.00K458.00K-1.79M-1.22M-1.26M-23.00K-31.00K-206.00K227.00K78.00K49.00K78.00K27.00K12.67M
Net Income-1.78K-1.35M435.00K-782.00K-1.35M2.99M-781.00K-2.54M-4.31M-2.53M-2.48M-1.39M-1.21M-1.26M2.59M-9.25M-24.94M-15.13M-14.02M-16.47M-14.29M-17.14M-12.67M
Interest ExpensesN/AN/AN/AN/A29.00K80.00K29.00K16.00K6.00K35.00K35.00K15.00K8.00K7.00K2.00K3.00K4.00KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding544.95M544.91M615.55M514.21M514.21M5.14M4.70M2.74M2.64M2.31M2.24M2.18M1.94M11.34M5.86M585.54K456.99K403.48K340.25K269.46K2.23M2.22M2.22M
Diluted Shares Outstanding544.91M544.91M615.55M514.21M514.21M5.14M4.70M2.74M2.64M2.31M2.24M2.18M1.94M11.34M5.88M585.54K456.99K403.48K3.37M2.75M2.23M2.22M2.22M
EBITDA-764.00K-879.00K-1.03M-947.00KN/A-792.00K-1.25M-2.56M-2.00M-1.97M-190.00K-2.17M-1.11M-1.22M2.58M-18.40M-25.03M-15.40M-12.37M-16.46M15.36M-17.71M-15.12M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-1,523.08%-4,293.10%-11,134.78%33,333.33%-4,802.44%-8.02%-231.88%0.00%0.00%0.00%-309.80%-2,759.98%-3,393.17%-386.93%-476.46%0.00%0.00%0.00%
EBIT-1.78K-880.00K-1.03M-948.00K-1.39M-4.57M-1.21M-1.70M-1.99M-1.99M-1.98M-3.16M-2.42M-2.51M2.57M-9.27M-25.14M-14.90M-13.94M-16.42M-14.21M-17.11MN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%-8,792.31%-4,168.97%-7,378.26%33,183.33%-4,846.34%-83.71%-337.10%0.00%0.00%0.00%-156.13%-2,771.89%-3,283.04%-435.94%-475.51%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙